orthostatic hypotension semaglutide GLP-1 and Low Blood Pressure: Symptoms, Risks, and Management Exacerbation of Postural Orthostatic Tachycardia

The SURMOUNT-5 trial showed that maximum-dose tirzepatide produces about 47% more weight loss than maximum-dose semaglutide, so they are clearly not equivalent at their respective maximums

Catagen : Transitional phase

It reports pathway-level variants in MTHFR, MTRR, and COMT that describe your baseline methylation and B12 biology, giving upstream context you can bring to a prescriber

In clinical trials, up to 20% of people taking semaglutide reported experiencing nausea

First-pass metabolism The metabolism of orally ingested compounds before reaching general circulation

The FDA approval is disease-specific, and the implant cannot be compounded, sold as an injectable, or prescribed off-label for cosmetic indications